14.05
-2.00
(-12.46%)
At close: January 14 at 4:00:02 PM EST
14.21
+0.16
+(1.14%)
After hours: 7:03:17 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 5 | 6 |
| Avg. Estimate | 0.46 | 0.42 | 1.23 | 1.98 |
| Low Estimate | 0.33 | 0.33 | 1.2 | 1.81 |
| High Estimate | 0.52 | 0.55 | 1.27 | 2.14 |
| Year Ago EPS | -- | -- | -- | 1.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 8 | 10 | 10 |
| Avg. Estimate | 1.48B | 1.52B | 5.84B | 6.3B |
| Low Estimate | 1.48B | 1.5B | 5.84B | 6.17B |
| High Estimate | 1.5B | 1.56B | 5.86B | 6.36B |
| Year Ago Sales | -- | -- | 5.41B | 5.84B |
| Sales Growth (year/est) | -- | -- | 8.02% | 7.77% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 |
|---|---|---|
| EPS Est. | 0.29 | 0.29 |
| EPS Actual | 0.4 | 0.24 |
| Difference | 0.11 | -0.05 |
| Surprise % | 37.28% | -16.12% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.46 | 0.42 | 1.23 | 1.98 |
| 7 Days Ago | 0.49 | 0.42 | 1.23 | 2.03 |
| 30 Days Ago | 0.51 | 0.4 | 1.25 | 2.01 |
| 60 Days Ago | 0.48 | 0.4 | 1.24 | 2 |
| 90 Days Ago | 0.4 | 0.38 | 1.28 | 2.03 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 3 | -- | -- |
| Up Last 30 Days | 7 | 2 | 1 | 3 |
| Down Last 7 Days | -- | 3 | -- | 1 |
| Down Last 30 Days | -- | 4 | 5 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARDT | -- | -- | -- | 60.53% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 11/14/2024 |
| Maintains | Leerink Partners: Outperform to Outperform | 11/12/2024 |
| Downgrade | B of A Securities: Buy to Neutral | 11/6/2024 |
| Initiated | Keybanc: Overweight | 10/11/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 9/19/2024 |
Related Tickers
CON Concentra Group Holdings Parent, Inc.
20.41
-1.07%
AUNA Auna SA
7.70
+5.77%
SGRY Surgery Partners, Inc.
19.85
-6.19%
GRDN Guardian Pharmacy Services, Inc.
20.47
-2.66%
SEM Select Medical Holdings Corporation
18.92
+0.64%
PACS PACS Group, Inc.
13.72
+2.85%
PNTG The Pennant Group, Inc.
26.51
+1.07%
LFST LifeStance Health Group, Inc.
7.76
+0.39%
CCRN Cross Country Healthcare, Inc.
18.16
-0.16%
HCSG Healthcare Services Group, Inc.
11.68
+1.04%